Hormones · Melatonin

Delayed estimated circadian phase is associated with greater restless legs syndrome symptom severity

In an exploratory pilot study of 21 patients with idiopathic RLS and 21 matched insomnia controls, patients with RLS showed a non-significant trend toward delayed estimated dim light melatonin onset (eDLMO) compared to controls (10:01 PM vs 9:33 PM, p=0.069, d=0.58). Within the RLS group, later eDLMO was modestly associated with higher RLS symptom severity scores (β=0.0726, p=0.038) after adjusting for age and depressive symptoms.

1 min readUpdated Jul 25, 20260 RCTsView structured evidence →
Evidence Score43/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★
Confidencelow

This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.

Delayed estimated circadian phase is associated with greater restless legs syndrome symptom severity The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 43/100 (low).

The Claim

Delayed estimated circadian phase is associated with greater restless legs syndrome symptom severity

This conclusion is most relevant to: Patients with idiopathic restless legs syndrome (mean age 61.2 years, 90% female) and age- and sex-matched chronic insomnia controls.

What the Research Shows

The conclusion draws on 1 linked study. Highlights from the cited literature:

  • Circadian Rhythm in Restless Legs Syndrome and Its Association With Symptom Severity: An Actigraphy-Based Study. (Journal of biological rhythms, 2026) —

How It Works

The proposed biological pathway:

  • Circadian phase delay may alter melatonin timing and neurotransmitter regulation
  • Delayed circadian phase could exacerbate evening symptom onset in RLS
  • Later eDLMO correlates with higher IRLS scores
  • Supports a link between circadian phase delay and clinical burden in RLS

Who Might Benefit

Evidence fit by population:

  • Patients with idiopathic restless legs syndrome (mean age 61.2 years, 90% female) and age- and sex-matched chronic insomnia controls

Limitations & Caveats

Important context when interpreting this evidence:

  • Exploratory pilot study with small sample size (n=21 per group)
  • eDLMO estimated from actigraphy model rather than direct salivary melatonin measurement

Frequently Asked Questions

What is eDLMO and how was it measured?

eDLMO stands for estimated dim light melatonin onset, which was derived from a mathematical model based on 14 days of wrist actigraphy data, not from direct melatonin sampling.

Was the circadian phase difference between RLS and insomnia groups statistically significant?

No, the difference was a non-significant trend (p=0.069) with a moderate effect size (Cohen's d=0.58).

Does this study prove that circadian delay causes worse RLS symptoms?

No, the study shows a modest association (β=0.0726, p=0.038) but cannot establish causality due to its observational and exploratory design.

What was the sample size and demographic of the study?

The study included 21 RLS patients and 21 insomnia controls, both groups with mean age around 61 years and 90% female.

References

  1. 1.Bang SY, Awan A, Lim D, Hwang S, Koo BB, Kim JK, Jung KY. “Circadian Rhythm in Restless Legs Syndrome and Its Association With Symptom Severity: An Actigraphy-Based Study..” Journal of biological rhythms, 2026. PMID: 42417186 DOI: 10.1177/07487304261456963
Disclaimer: This article is auto-generated from structured research data for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.